BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Etchevers MJ, Aceituno M, Sans M. Are we giving azathioprine too late? The case for early immunomodulation in inflammatory bowel disease. World J Gastroenterol 2008; 14(36): 5512-5518 [PMID: 18810768 DOI: 10.3748/wjg.14.5512]
URL: https://www.wjgnet.com/1007-9327/full/v14/i36/5512.htm
Number Citing Articles
1
P. C. Church, D. Turner, B. M. Feldman, T. D. Walters, M.‐L. Greer, M. M. Amitai, A. M. Griffiths. Systematic review with meta‐analysis: magnetic resonance enterography signs for the detection of inflammation and intestinal damage in Crohn's diseaseAlimentary Pharmacology & Therapeutics 2015; 41(2): 153 doi: 10.1111/apt.13024
2
Fernando Gomollón, Javier P. Gisbert. ¿Es necesario asociar inmunomoduladores al tratamiento biológico en la enfermedad inflamatoria intestinal?Gastroenterología y Hepatología 2010; 33(1): 43 doi: 10.1016/j.gastrohep.2009.03.008
3
Balakrishnan S. Ramakrishna, Govind K. Makharia, Philip Abraham, Uday C. Ghoshal, Venkataraman Jayanthi, Brij Kishore Agarwal, Vineet Ahuja, Deepak K. Bhasin, Shobna J. Bhatia, Gourdas Choudhuri, Sunil Dadhich, Devendra C. Desai, Gopal Krishna Dhali, Bhaba Dev Goswami, Sanjeev K. Issar, Ajay K. Jain, Rakesh Kochhar, Ajay Kumar, Goundappa Loganathan, Sri Prakash Misra, C. Ganesh Pai, Sujoy Pal, Anna Pulimood, Amarender S. Puri, Ganesh N. Ramesh, Gautam Ray, Shivaram P. Singh, Ajit Sood, Manu Tandan. Indian Society of Gastroenterology consensus on ulcerative colitisIndian Journal of Gastroenterology 2012; 31(6): 307 doi: 10.1007/s12664-012-0259-0
4
Lorenz Grob, Sena Bluemel, Luc Biedermann, Nicolas Fournier, Jean-Benoit Rossel, Stephan R. Vavricka, Jonas Zeitz, Gerhard Rogler, Andreas Stallmach, Michael Scharl. Effect of distance to specialist care for the diagnosis and disease outcome of inflammatory bowel disease in the Swiss inflammatory bowel disease cohort studyTherapeutic Advances in Gastroenterology 2020; 13 doi: 10.1177/1756284819895217
5
J.V. Arcos-Machancoses, E. Donat-Aliaga, B. Polo-Miquel, E. Masip-Simó, C. Ribes-Koninckx, A. Pereda-Pérez. Retraso diagnóstico en la enfermedad inflamatoria intestinal pediátrica. Descripción y estudio de los factores de riesgoAnales de Pediatría 2015; 82(4): 247 doi: 10.1016/j.anpedi.2014.05.024
6
Stephan R. Vavricka, Sabrina M. Spigaglia, Gerhard Rogler, Valérie Pittet, Pierre Michetti, Christian Felley, Christian Mottet, Christian P. Braegger, Daniela Rogler, Alex Straumann, Peter Bauerfeind, Michael Fried, Alain M. Schoepfer. Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel diseaseInflammatory Bowel Diseases 2012; 18(3): 496 doi: 10.1002/ibd.21719
7
Makoto Naganuma, Atsushi Sakuraba, Toshifumi Hibi. Ulcerative colitis: prevention of relapseExpert Review of Gastroenterology & Hepatology 2013; 7(4): 341 doi: 10.1586/egh.13.18
8
Cristina Ribeiro de Barros Cardoso, Amanda de Castro Habka, Camila Figueiredo Pinzan, Camilla Narjara Simão Oliveira, Jefferson Luiz da Silva, Murillo Duarte-Silva. Biological Therapy for Inflammatory Bowel Disease2020;  doi: 10.5772/intechopen.90009
9
J.V. Arcos-Machancoses, E. Donat-Aliaga, B. Polo-Miquel, E. Masip-Simó, C. Ribes-Koninckx, A. Pereda-Pérez. Description and study of risk factors for the diagnostic delay of paediatric inflammatory bowel diseaseAnales de Pediatría (English Edition) 2015; 82(4): 247 doi: 10.1016/j.anpede.2015.03.004
10
Ho Suk Kang, Ja Seol Koo, Kang Moon Lee, Dae Bum Kim, Ji Min Lee, Yoon Jae Kim, Hyuk Yoon, Hyun Joo Jang. Two-year delay in ulcerative colitis diagnosis is associated with anti-tumor necrosis factor alpha useWorld Journal of Gastroenterology 2019; 25(8): 989-1001 doi: 10.3748/wjg.v25.i8.989
11
Manuel Barreiro-de Acosta, Fernando Magro, Daniel Carpio, Paula Lago, Ana Echarri, José Cotter, Santos Pereira, Raquel Gonçalves, Aurelio Lorenzo, Laura Carvalho, Javier Castro, Luisa Barros, Jorge Amil Dias, Susana Rodrigues, Francisco Portela, Camila Dias, Altamiro da Costa-Pereira. Ulcerative colitis in northern Portugal and Galicia in SpainInflammatory Bowel Diseases 2010; 16(7): 1227 doi: 10.1002/ibd.21170
12
Deepa K. Ingawale, Satish K. Mandlik, Suresh R. Naik. Models of hepatotoxicity and the underlying cellular, biochemical and immunological mechanism(s): A critical discussionEnvironmental Toxicology and Pharmacology 2014; 37(1): 118 doi: 10.1016/j.etap.2013.08.015
13
Kalle Landerholm, Disa Kalman, Conny Wallon, Pär Myrelid. Immunomodulators: Friends or Enemies in Surgery for Crohn’s Disease?Current Drug Targets 2019; 20(13): 1384 doi: 10.2174/1389450120666190617163919
14
Nandini Nagaraj, Joseph Sellin. Colorectal Surgery2013; : 339 doi: 10.1016/B978-1-4377-1724-2.00021-0
15
Alain M. Schoepfer, Stephan Vavricka, Ekaterina Safroneeva, Nicolas Fournier, Christine Manser, Pascal Frei, Pierre Deltenre, Gerhard Rogler, Alex Straumann, Jessica Ezri, Andreas Nydegger, Christian Braegger. Systematic Evaluation of Diagnostic Delay in Pediatric Inflammatory Bowel DiseaseJournal of Pediatric Gastroenterology and Nutrition 2017; 64(2): 245 doi: 10.1097/MPG.0000000000001238
16
Andrea Cossu, Livia Biancone, Marta Ascolani, Francesco Pallone, Monica Boirivant. “In vitro” azathioprine-induced changes in peripheral T cell apoptosis and IFN-γ production associate with drug response in patients with Crohn's DiseaseJournal of Crohn's and Colitis 2013; 7(6): 441 doi: 10.1016/j.crohns.2012.06.020
17
Susann Hasler, Nadine Zahnd, Salomé Müller, Stephan Vavricka, Gerhard Rogler, Ryan Tandjung, Thomas Rosemann. VAlidation of an 8-item-questionnaire predictive for a positive caLprotectin tEst and Real-life implemenTation in primary care to reduce diagnostic delay in inflammatory bowel disease (ALERT): protocol for a prospective diagnostic studyBMJ Open 2015; 5(3): e007306 doi: 10.1136/bmjopen-2014-007306
18
Sandro Ardizzone, Andrea Cassinotti, Gianpiero Manes, Gabriele Bianchi Porro. Review: Immunomodulators for all patients with inflammatory bowel disease?Therapeutic Advances in Gastroenterology 2010; 3(1): 31 doi: 10.1177/1756283X09354136
19
Laurent Peyrin-Biroulet, Gionata Fiorino, Anthony Buisson, Silvio Danese. First-line therapy in adult Crohn's disease: who should receive anti-TNF agents?Nature Reviews Gastroenterology & Hepatology 2013; 10(6): 345 doi: 10.1038/nrgastro.2013.31
20
Alain M Schoepfer, Mohamed-Ali Dehlavi, Nicolas Fournier, Ekaterina Safroneeva, Alex Straumann, Valérie Pittet, Laurent Peyrin-Biroulet, Pierre Michetti, Gerhard Rogler, Stephan R Vavricka. Diagnostic Delay in Crohn's Disease Is Associated With a Complicated Disease Course and Increased Operation RateAmerican Journal of Gastroenterology 2013; 108(11): 1744 doi: 10.1038/ajg.2013.248
21
Antony Aziz, Rebecca Reynolds, Azhar Ansari. Process and Systems: A population-based model of care for people with inflammatory bowel disease – patient-reported outcomesFuture Healthcare Journal 2019; 6(1): 30 doi: 10.7861/futurehosp.6-1-30
22
Pearl Avery. The cost of treating inflammatory bowel disease: step-up vs step-down, therapeutic drug monitoring and personalised medicineGastrointestinal Nursing 2021; 19(4): 18 doi: 10.12968/gasn.2021.19.4.18
23
Giovanni C Actis, Rinaldo Pellicano, Mario Rizzetto, Muhammad Ayoubi, Nicola Leone, Gianfranco Tappero, Paola Pazienza, Floriano Rosina. Individually administered or co-prescribed thiopurines and mesalamines for inflammatory bowel diseaseWorld Journal of Gastroenterology 2009; 15(12): 1420-1426 doi: 10.3748/wjg.15.1420
24
J.M. Marugán de Miguelsanz, S. Abad Arevalillo, P. Redondo del Río, M. Marcos Temprano. ¿Cómo debemos actuar en pacientes con colitis ulcerosa e infección por citomegalovirus?Anales de Pediatría 2014; 80(2): 127 doi: 10.1016/j.anpedi.2013.04.014
25
Tarsila Campanha da Rocha Ribeiro, Liliana Andrade Chebli, Pedro Duarte Gaburri, Julio Maria Fonseca Chebli. Azathioprine in ulcerative colitis: Why, when, how and how long to use itDrug Development Research 2011; 72(8): 733 doi: 10.1002/ddr.20481
26
Gokhan Okan, Pervin Vural, Onder Peker, Emel Colakoglu, Murat Saruc. Azathioprine-induced liver injury in a patient with multiple autoimmune syndromeJournal of Dermatological Treatment 2010; 21(6): 357 doi: 10.3109/09546630903410174
27
Maggie Lee, Jennifer Kovacs-Nolan, Tania Archbold, Ming Z. Fan, Lekh R. Juneja, Tutomu Okubo, Yoshinori Mine. Therapeutic potential of hen egg white peptides for the treatment of intestinal inflammationJournal of Functional Foods 2009; 1(2): 161 doi: 10.1016/j.jff.2009.01.005
28
Choon Jin Ooi, Kwong Ming Fock, Govind K Makharia, Khean Lee Goh, Khoon Lin Ling, Ida Hilmi, Wee Chian Lim, Thia Kelvin, Peter R Gibson, Richard B Gearry, Qin Ouyang, Jose Sollano, Sathaporn Manatsathit, Rungsun Rerknimitr, Shu‐chen Wei, Wai Keung Leung, H Janaka De Silva, Rupert WL Leong. The Asia‐Pacific consensus on ulcerative colitisJournal of Gastroenterology and Hepatology 2010; 25(3): 453 doi: 10.1111/j.1440-1746.2010.06241.x
29
Qiufang Liang, Xiaofeng Ren, Meram Chalamaiah, Haile Ma. Simulated gastrointestinal digests of corn protein hydrolysate alleviate inflammation in caco-2 cells and a mouse model of colitisJournal of Food Science and Technology 2020; 57(6): 2079 doi: 10.1007/s13197-020-04242-7
30
Giulia Straforini, Ramona Brugnera, Rosy Tambasco, Fernando Rizzello, Paolo Gionchetti, Massimo Campieri. Attualità e controversie nella terapia delle malattie infiammatorie croniche intestinaliItalian Journal of Medicine 2009; 3(3): 179 doi: 10.1016/j.itjm.2009.02.001
31
Jacob Tveiten Bjerrum, Yulan Wang, Fuhua Hao, Mehmet Coskun, Christian Ludwig, Ulrich Günther, Ole Haagen Nielsen. Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn’s disease and healthy individualsMetabolomics 2015; 11(1): 122 doi: 10.1007/s11306-014-0677-3
32
Jacques Cosnes, Philippe Seksik. Early Azathioprine in Crohnʼs DiseaseInflammatory Bowel Diseases 2013; 19(3): 674 doi: 10.1097/MIB.0b013e318281d697